Drug- and herb-induced liver injury: A case series from a single center

Turkish Journal of Gastroenterology

Volumn 25, Issue 1, 2014, Pages 41-45

  Daǧ, Muhammed Sait ^a   Aydinli, Musa ^a   Öztürk, Zeynel Abidin ^a   Türkbeyler, Ibrahim Halil ^b   Koruk, Irfan ^a   Savaş, Muhammet Cemil ^a   Koruk, Mehmet ^a   Kadayifçi, Abdurrahman ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Kilis State Hospital   (Turkey)

Author keywords

Drug; Hepatitis; Herbal preparation; Toxicity

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTILIPEMIC AGENT; ANTITHYROID AGENT; DICLOFENAC; FLURBIPROFEN; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; ISONIAZID PLUS RIFAMPICIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; ANTIINFECTIVE AGENT; PLANT MEDICINAL PRODUCT;

ACUTE LIVER FAILURE; ADULT; ARTICLE; CASE STUDY; FEMALE; GERMANDER; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; LIVER INJURY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; DRUG-INDUCED LIVER INJURY; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; TURKEY;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT PREPARATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TURKEY;

EID: 84902594381     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.5152/tjg.2014.4486     Document Type: Article

References (30)

1. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-5. [CrossRef ] (Pubitemid 34810366)
2. Hussaini SH, O'Brien CS, Despott EJ, Dalton HR. Antibiotic therapy a major cause of drug-induced jaundice in southwest England. Eur. J. Gastroenterol. Hepatol 2007; 19: 15-20. [CrossRef ] (Pubitemid 46066863)
3. Friis H, Andreasen PB. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish committee on adverse drug reactions between 1978 and 1987. J Intern Med 1992; 232: 133-8. [CrossRef]
4. Pillans PI. Drug associated hepatic reactions in New Zealand: 21 years' experience. N Z Med J 1996; 109: 315-9. (Pubitemid 26278242)
5. Dossing M, Andreasen PB. Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish board of adverse reactions to drugs. Scand J Gastroenterol 1982; 17: 205-11. [CrossRef ] (Pubitemid 12185523)
6. Galan MV, Potts JA, Silverman AL, Gordon SC. The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center. J Clin Gastroenterol 2005; 39: 64-7. (Pubitemid 40041347)
7. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-54. [CrossRef ] (Pubitemid 35440240)
8. Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005; 27: 1847-58. [CrossRef ] (Pubitemid 41815236)
9. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343: 1-19.
10. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34. [CrossRef]
11. Estes JD, Stolpman D, Olyaei A, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003; 138: 852-8. [CrossRef ] (Pubitemid 36960946)
12. Wang YP, Shi B, Chen YX, Xu J, Jiang CF, Xie WF. Drug-induced liver disease: an 8-year study of patients from one gastroenterological department. J Dig Dis 2009; 10: 195-200. [CrossRef]
13. Wai CT, Tan BH, Chan CL, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007; 27: 465-74. [CrossRef]
14. Garci'a-Corte's M, Borraz Y, Lucena MI, et al. (Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish liver toxicity registry). Rev Esp Enferm Dig 2008; 100: 688-95.
15. Bénichou C. Criteria of drug induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-6. [CrossRef]
16. Andrade, RJ, Lucena, MI, Fernández MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-21. [CrossRef ] (Pubitemid 41096639)
17. Idilman R, Bektas M, Cinar K, et al. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience. J Clin Gastroenterol 2010; 44: 128-32. [CrossRef]
18. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting. Int J Clin Pharmacol Ther Toxicol 1990; 28: 317-22.
19. Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006; 43: 618-31. [CrossRef]
20. Lucena MI, Camargo R, Andrade RJ, Perez-Sanchez CJ, Sanchez De La Cuesta F. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 2001; 33: 23-30. [CrossRef]
21. Ibanez L, Perez E, Vidal X, et al. Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 2002; 37: 592-600. [CrossRef ] (Pubitemid 35305538)
22. Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42: 481-9. [CrossRef] (Pubitemid 41061102)
23. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National health and nutritional examination survey (NHANES III). Pharmacoepidemiol Drug Saf 2003; 12: 315-26. [CrossRef ] (Pubitemid 36700608)
24. Laine L. Gastrointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage 2003; 25: 32-40. [CrossRef]
25. García Rodríguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with nonsteroidalanti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994; 154: 311-6. [CrossRef] (Pubitemid 24055884)
26. Lanza LL, Walker AM, Bortnichak EA, et al. Incidence of symptomatic liver function abnormalities in a cohort of NSAID users. Pharmacoepidemiol Drug Saf 1995; 4: 231-7. [CrossRef]
27. Ganey PE, Luyendyk JP, Maddox JF, Roth RA. Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact 2004; 150: 35-51. [CrossRef ] (Pubitemid 39441294)
28. Hautekeete ML, Brenard R, Horsmans Y, et al. Liver injury related to amoxicillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. J Hepatol 1995; 22: 71-7. [CrossRef]
29. Savvidou S, Goulis J, Giavazis I, Patsiaoura K, Hytiroglou P, Arvanitakis C. Herb-induced hepatitis by teucrium polium L.: report of two cases and review of the literature. Eur J Gastroenterol Hepatol 2007; 19: 507-11. [CrossRef ] (Pubitemid 46725758)
30. Mattéi A, Rucay P, Samuel D, Feray C, Reynes M, Bismuth H. Liver transplantation for severe acute liver failure after herbal medicine (teucrium polium) administration. J Hepatol 1995; 22: 597-9. [CrossRef]